Use of aspirin versus clopidogrel plus Aspirin after coronary artery bypass graft surgery

Clinical and Applied Thrombosis/Hemostasis

Volumn 15, Issue 5, 2009, Pages 540-544

  Sanon, Saurabh ^a   Lee, Vei Vei ^b   Elayda, MacArthur ^b   Wilson, James M ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

Author keywords

Antiplatelet therapy; Aspirin; Aspirin clopidogrel combination therapy; Clopidogrel; Coronary artery bypass graft surgery

Indexed keywords

ACETYLSALICYLIC ACID; ACETYLSALICYLIC ACID PLUS CLOPIDOGREL; CLOPIDOGREL; UNCLASSIFIED DRUG;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY BYPASS SURGERY; FEMALE; FOLLOW UP; GRAFT SURVIVAL; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PRESCRIPTION; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SCORING SYSTEM;

AGED; ASPIRIN; CORONARY ARTERY BYPASS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVORS; TICLOPIDINE;

EID: 70449638767     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/1076029608328570     Document Type: Article

References (13)

1. Buxton BF, Fuller J. Clinical trials and graft patency data in coronary artery surgery-a 30-year perspective. Heart Lung Circ. 2004 ; 13 (suppl 3). S7 - S12.
2. Fitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol. 1997 ; 29: 706-707.
3. The Post Coronary Artery Bypass Graft Trial Investigators. The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts. N Engl J Med. 1997 ; 337: 1859.
4. Knatterud GL, Rosenberg Y., Campeau L., et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation. 2000 ; 102: 144-146.
5. Fox KA, Mehta SR, Peters R., et al. and Clopidogrel in Unstable angina to prevent Recurrent ischemic Events Trial. Benefits and risks of the combination of clopidogrel and aspirin in patients undergoing surgical revascularization for non-ST-elevation acute coronary syndrome: the Clopidogrel in Unstable angina to prevent Recurrent ischemic Events (CURE) Trial. Circulation. 2004 ; 110: 1202-1208.
6. Thom T., Haase N., Rosamond W., et al. and American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2006 ; 113: e85 - e151.
7. Desai ND, Cohen EA, Naylor CD, Fremes SE, and Radial Artery Patency Study Investigators. A randomized comparison of radial-artery and saphenous-vein coronary bypass grafts. N Engl J Med. 2004 ; 351: 2302-2309.
8. Rupprecht HJ, Hamm C., Ischinger T., Dietz U., Reimers J., Meyer J. Angiographic follow-up results of a randomized study on angioplasty versus bypass surgery (GABI trial). GABI Study Group. Eur Heart J. 1996 ; 17: 1140-1141.
9. Bourassa MG Fate of venous grafts: the past, the present, and the future. J Am Coll Cardiol. 1991 ; 17: 1081-1083.
10. Shuhaiber JH, Evans AN, Massad Mg, Geha AS Mechanisms and future directions for prevention of vein graft failure in coronary bypass surgery. Eur J Cardiothoracic Surg. 2002 ; 22: 387-396.
11. Shah PJ, Gordon I., Fuller J., et al. Factors affecting saphenous vein graft patency: clinical and angiographic study in 1402 symptomatic patients operated on between 1977 and 1999. J Thorac Cardiovasc Surg. 2003 ; 126: 1972-1977.
12. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996 ; 348: 1329-1339.
13. Beinart SC, Kolm P., Veledar E., et al. Long-term cost effectiveness of early and sustained dual oral antiplatelet therapy with clopidogrel given for up to one year after percutaneous coronary intervention results: from the Clopidogrel for the Reduction of Events During Observation (CREDO) trial. J Am Coll Cardiol. 2005 ; 46: 761-769.